In the last trading session, 1.04 million shares of the Adc Therapeutics SA (NYSE:ADCT) were traded, and its beta was 1.92. Most recently the company’s
Adc Therapeutics SA (NYSE:ADCT)’s traded shares stood at 0.32 million during the last session, with the company’s beta value hitting 1.92. At the close of
In the last trading session, 2.21 million Adc Therapeutics SA (NYSE:ADCT) shares changed hands as the company’s beta touched 1.92. With the company’s per share
In last trading session, Adc Therapeutics SA (NYSE:ADCT) saw 1.08 million shares changing hands with its beta currently measuring 1.94. Company’s recent per share price
Adc Therapeutics SA (NYSE:ADCT) has a beta value of -54.37% and has seen 563.71 shares traded in the last trading session. The company, currently valued
Adc Therapeutics SA (NYSE:ADCT)’s traded shares stood at 0.83 million during the last session, with the company’s beta value hitting 1.97. At the close of
Adc Therapeutics SA (NYSE:ADCT) has a beta value of 1.97 and has seen 1.69 million shares traded in the last trading session. The company, currently
During the last session, Adc Therapeutics SA (NYSE:ADCT)’s traded shares were 1.14 million, with the beta value of the company hitting 1.82. At the end
After receiving approval for a breakthrough medicine, ADC Therapeutics SA (NYSE: ADCT) is soaring today, up 15.70% to trade at $3.68 at the last check
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne